Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

175 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Completed

A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)

NCT02593760

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Florida Cancer Specialists-Broadway, Fort Myers Fort Myers, Florida, United States
  • Florida Cancer Specialist, North Region St. Petersburg, Florida, United States
  • Florida Cancer Specialists West Palm Beach, Florida, United States
  • Oncology Hematology Care Inc Cincinnati, Ohio, United States
View all 13 locations
View Trial Details
Completed

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

NCT00572897

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

NCT01520220

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
View Trial Details
Completed

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

NCT01398462

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions